Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations like AML, MDS and breast cancer. Over the course of January, the Food and ...
0037). 1. The FDA has approved sotorasib (Lumakras, Amgen Inc.) with panitumumab (Vectibix, Amgen Inc.) for certain adult patients with metastatic colorectal cancer (CRC). More specifically ...
Feb. 5. 2025 – The FDA has approved a new pill to treat adults with a type of blood cancer called mantle cell lymphoma (MCL). This treatment is for people who are newly diagnosed or haven't h ...
The FDA has issued a complete response letter (CRL) to Spectrum Pharma for poziotinib, its pan HER2 inhibitor for a form of lung cancer, according to South Korea's Hanmi Pharma, which originally ...
The FDA advances in multiple cancer types, and researchers assess potential impacts of funding freezes on cancer research.
The drug cocktail includes Braftovi, Eli Lilly’s Erbitux and the chemo regimen mFOLFOX6. In patients with metastatic colorectal cancer harboring a BRAF V600E mutation, the combo not only staved ...
The approval highlights the importance of accurate HER2 testing and expands personalized treatment strategies for HER2-low and -ultralow breast cancer. Dr. Debu Tripathy breaks down the FDA approval ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback